Dental caries is a chronic health problem that impacts the majority of the global population.^[@ref1]^ Although culture-independent sequencing has illuminated the complexity of the human oral microbiome, *Streptococcus mutans* remains widely regarded as a primary etiological agent in caries.^[@ref2],[@ref3]^ This facultatively anaerobic, microaereophilic, Gram-positive, bacterium excels in the complex environment of the oral cavity where stresses including low pH and an oxidative environment are coupled to variable salivary flow and carbohydrate supply.^[@ref4]^ The physiologic adaptations of *S. mutans* to these pressures provide a competitive advantage versus noncariogenic commensals that underpins the establishment and progression of caries.^[@ref5]^

Broad-spectrum agents such as fluoride and chlorhexidine represent the state-of-the-art in anticariogenic preventative treatment, although the efficacy of chlorhexidine remains debated.^[@ref6]^ Significant perturbation of the oral microbiome accompanies their use,^[@ref7]^ and there is increasing evidence that such imbalances can favor pathogens versus commensals.^[@ref8]^ Compounds that are species- or phenotype-selective would allow exploration of the hypothesis that targeting smaller elements of complex communities may be advantageous.^[@ref9]^ In this light, we were attracted to a report describing the structure and activity of the myxobacterial metabolite carolacton (**1**, Figure [1](#fig1){ref-type="fig"}).^[@ref10]^ Initial characterizations showed that carolacton causes 35--66% cell death within *S. mutans* biofilms at concentrations ranging from 5 to 25 ng/mL. Remarkably, planktonic cultures of *S. mutans* were not affected by carolacton, nor were a variety of other bacteria.

![Carolacton structure and an overview of key features in the synthesis that traces to lactone **4** and β-ketoimide **5**.](ol-2014-00004k_0001){#fig1}

The structure and activity of carolacton has attracted much scientific interest. Kirschning has completed a total synthesis, and several subunit syntheses have also been reported.^[@ref11]^ In addition, a number of investigations have pursued in more detail the biology of carolacton's effects on *S. mutans* and the question of its mode-of-action.^[@ref12]^ While there is accord on the differential activity of carolacton for biofilm versus planktonic cultures of *S. mutans*, coherency around mode-of-action has yet to emerge.

In this Letter, we describe a straightforward synthesis of carolacton that is amenable to an extensive exploration of structure--function relationships. Key elements of the synthesis are shown in Figure [1](#fig1){ref-type="fig"}, including an assembly strategy that leverages macrocycle formation by esterification and a ring-closing metathesis, followed by a selective olefin hydrogenation.

The synthesis of the C12--C19 acid **2** began with known gulonolactone-derived diol **6**([@ref13]) (available in 4 steps, 62% overall from [d]{.smallcaps}-gulonolactone, Scheme [1](#sch1){ref-type="scheme"}). Oxidative cleavage of the diol with sodium periodate on silica^[@ref14]^ gave aldehyde **7**, which was subjected to a *Z*-selective Wittig olefination to yield alkene **8**. Removal of the benzoate, followed by Swern oxidation, provided the key lactone **4**. In accord with Trost's studies,^[@ref15]^ exposing **4** to allylmagnesium bromide in the presence of CuBr·SMe~2~ resulted in S~N~2′ opening of the lactone to produce acid **2** in 60% yield and as a single diastereomer.

![Synthesis of the C12--C19 Subunit **2** from Gulonolactone-Derived Diol **6**](ol-2014-00004k_0003){#sch1}

The stereochemically complex C1--C11 domain was assembled as shown in Scheme [2](#sch2){ref-type="scheme"}. Enolization of the Evans β-ketoimide **5** under conditions favoring formation of the (*E*)-enol borane, followed by reaction with aldehyde **9**, produced **10** in 81% yield and with a dr of 5:1.^[@ref16]^ Separation of the diastereomers was not possible. Conveniently, the subsequent three-step sequence of methylation, reduction, and oxidation--Wittig olefination not only proceeded in 48% overall yield but also allowed for isolation of enoate **12** as a single diastereomer. Silylation of the alcohol gave TBS ether **13**. Introduction of the final two stereocenters was readily achieved by conversion of the ester to an aldehyde and application of Leighton's (*R*,*R*)-*trans* EZ-CrotylMix to give alcohol **3** (61%, 5:1 dr).^[@ref17]^

![Synthesis of the C1--C11 Subunit **3**](ol-2014-00004k_0004){#sch2}

With routes to the two key subunits secured, it was possible to investigate the end-game for the synthesis, which began with a Steglich esterification to connect acid **2** and alcohol **3**, producing a near-quantitative yield of **14** (Scheme [3](#sch3){ref-type="scheme"}). Reaction of **14** with 5.5 mol % of the second-generation Grubbs catalyst was unsurprisingly selective for the terminal olefins and led to lactone **15** in 76% yield. Our plans demanded a selective hydrogenation of the Δ^11,12^ olefin at this juncture, a strategy predicated on conformational analysis of **15** suggesting peripheral addition would favor the desired reduction.^[@ref18]^ Pleasingly, this was borne out under operationally simple conditions: subjecting **15** to 5% Pd/C in EtOH under a hydrogen balloon resulted in selective reduction of the Δ^11,12^ olefin as well as removal of the PMB group (70% yield). Removal of the TBS ether with TBAF produced diol **16** in 96% yield and set the stage for a simultaneous oxidation of the primary and secondary alcohols under Swern conditions and subsequent Lindgren--Pinnick oxidation to yield keto-acid **17**. Removal of the acetonide yielded synthetic carolacton (**1**). Analytical characteristics of this material were in full accord with data reported for the natural product.

![Subunit Coupling and Completion of the Synthesis](ol-2014-00004k_0005){#sch3}

Our initial synthetic venture provided multimilligram amounts of intermediates in the late stages of the synthesis. We capitalized on this to perform a preliminary biological evaluation of compounds **16**, **17**, and carolacton against *S. mutans* UA159 grown planktonically and also within a biofilm. None of the compounds displayed any inhibitory activity against planktonic cells at concentrations \<250 μM. In the case of carolacton, this is in accord with previous reports.^[@cit12b]^ However, when the compounds were incubated with *S. mutans* in the presence of biofilm-inducing media, dramatic morphological and architectural changes to the biofilm matrix were observed (Figure [2](#fig2){ref-type="fig"}). Confocal microscopy with LIVE/DEAD staining demonstrated that carolacton (\>500 nM) and **16** (\>62.5 μM) significantly affected both the integrity and morphology of the biofilm matrix when compared to the DMSO control. In contrast, compound **17** had no observable effect at concentrations \<250 μM. While the reasons for the significant difference in activity between compound **16** and **17** remain unclear at this time, our preliminary investigations provide credence to the suggestion that a minimal set of features needed for activity in the carolacton family might be readily identified by synthesis. Future efforts will focus on expanding the understanding of structure--function relationships in the carolacton class, as well as obtaining a detailed understanding of the mechanism of action of carolacton on *S. mutans* biofilms.

![Confocal microscopy imaging of *S. mutans* UA159 biofilm cells treated with 250 μM (a) DMSO, (b) carolacton, (c) **17**, and (d) **16**.](ol-2014-00004k_0002){#fig2}

Experimental methods and data, including spectra, for new compounds. This material is available free of charge via the Internet at <http://pubs.acs.org>.
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